显微微血管减压术(M-MVD)是缓解长期半面肌痉挛(HFS)的经典治疗方法。最近引入了一种内窥镜技术来改善M-MVD;然而,这个应用程序仍然有争议。这项研究比较了内窥镜辅助微血管减压术(EA-MVD)和M-MVD治疗HFS的安全性和有效性。从2021年2月至2022年9月,我们招募了49例HFS患者,分为EA-MVD(n=26)和M-MVD(n=23)组。对患者进行了ParkYS等级评估,手术时间,医院的日子,和并发症。在术后早期进行评估,一个月后,3个月,6个月,至少12个月.EA-MVD组23例(23/26,88.5%)患者和M-MVD组20例(20/23,87.0%)患者无痉挛缓解,范围超过“优秀”和“良好”公园YS等级。EA-MVD和M-MVD组手术时间分别为143±28min和145±22min(p=0.002)。EA-MVD和M-MVD组的住院时间分别为6.8±0.8天和7.2±1.3天(p=0.002),分别。HFS的所有手术都成功了,没有死亡,中风,听力损失,面部麻木,或其他极端并发症。总之,EA-MVD,与M-MVD相比,显示出同样有效的结果,减少了手术时间和住院时间,提供明亮的术中照明和灵活的手术视野。
Microscopic microvascular decompression (M-MVD) is a classical treatment for relieving long-term hemifacial spasms (HFS). An endoscopy technique has recently been introduced to improve M-MVD; however, this application remains debatable. This study compared the safety and effectiveness of endoscope-assisted microvascular decompression (EA-MVD) and M-MVD for HFS. From February 2021 to September 2022, we enrolled 49 patients with HFS assigned to the EA-MVD (n = 26) and M-MVD (n = 23) groups. The patients were assessed with Park YS grades, operative time, hospital days, and complications. Evaluations were performed in the early postoperative period, at one month, 3 months, 6 months, and at least 12 months. Twenty-three (23/26, 88.5%) patients in the EA-MVD group and 20 (20/23, 87.0%) patients in the M-MVD group achieved spasm-free relief, ranging over \"excellent\" and \"good\" Park YS grades. The operative time in the EA-MVD and M-MVD groups were 143 ± 28 min and 145 ± 22 min (p = 0.002). The duration of hospital stay was 6.8 ± 0.8 days and 7.2 ± 1.3 days in the EA-MVD and M-MVD groups (p = 0.002), respectively. All surgeries for HFS were successful, with no death, stroke, hearing loss, facial numbness, or other extreme complications. In conclusion, EA-MVD, compared with M-MVD, demonstrated equally effective outcomes with decreased operative time and hospital stays, providing bright intraoperative illumination and flexible surgical vision.